Medpace

Yahoo Finance • 19 days ago

Reasons to Hold Veeva Systems Stock in Your Portfolio for Now

Veeva Systems Inc. VEEV is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by a solid third-quarter fiscal 2026 performance and strategic deals, is expected to contribute further.... Full story

Yahoo Finance • 23 days ago

Medpace (MEDP): Has the Recent Pullback Opened a Valuation Opportunity for Long‑Term Investors?

Recent Performance and Context for Medpace Holdings Medpace Holdings (MEDP) has quietly pulled back over the past month after a strong run this year, and that dip is catching investors attention as they reassess what has driven the stock... Full story

Yahoo Finance • 25 days ago

Strategists are bullish on healthcare in 2026: 3 top stock picks

Catalyst Funds chief investment officer and senior portfolio manager David Miller and Marketgauge.com chief strategist Michele Schneider join Morning Brief host Julie Hyman to share some of their top stock picks in the healthcare (XLV) sec... Full story

Yahoo Finance • last month

Medpace Holdings (MEDP) Surged Following the Strong Results

Wasatch Global Investors, an asset management company, released its third-quarter 2025 “Wasatch Small Cap Growth Strategy” investor letter. A copy of the letter can be downloaded here. US small-cap equities rallied strongly in the third qu... Full story

Yahoo Finance • last month

What Makes Medpace Holdings (MEDP) an Investment Choice?

Giverny Capital Asset Management, LLC, an investment management company, recently published its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The portfolio generated good results in the third quarter and... Full story

Yahoo Finance • last month

Medpace Holdings, Inc. (MEDP): A Bull Case Theory

We came across a bullish thesis on Medpace Holdings, Inc. on Archive Invest’s Substack by Felix. In this article, we will summarize the bulls’ thesis on MEDP. Medpace Holdings, Inc.'s share was trading at $592.46 as of November 28th. MEDP’... Full story

Yahoo Finance • 2 months ago

Dow Jones Futures: Market At Key Level; Nvidia Falls On Google News

Futures wavered with the stock market at a key level. Nvidia fell on Google AI chip news. Alibaba rose on mixed results. Continue Reading View Comments... Full story

Yahoo Finance • 2 months ago

Dow Jones Futures Rise With Market At Key Level; Nvidia Falls On Google News

Futures wavered with the stock market at a key level. Nvidia fell on Google AI chip news. Alibaba rose on mixed results. Continue Reading View Comments... Full story

Yahoo Finance • 2 months ago

Dow Jones Futures Fall With Market At Key Level; Nvidia Falls On Google News

Futures fell after the stock market jumped up to a key level. Nvidia fell on Google AI chip news. Alibaba rose on mixed results. Continue Reading View Comments... Full story

Yahoo Finance • 2 months ago

Dow Jones Futures: Stock Market At Key Level; Nvidia Falls On Google News

Futures fell after the stock market jumped up to a key level. Nvidia fell on Google AI chip news. Alibaba rose on mixed results. Continue Reading View comments... Full story

Yahoo Finance • 2 months ago

BrightSpring Health Services, 10x Genomics, QuidelOrtho, Medpace, and Fortrea Shares Are Soaring, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after reports revealed the Trump administration considered extending the Affordable Care Act (ACA) subsidies. These subsidies, which are government financial aids to help p... Full story

Yahoo Finance • 2 months ago

Dow Jones Futures: What To Do As Stock Market Roars To Key Level; Tesla, Palantir, Broadcom Jump

The stock market jumped to a key level, but the jury's still out. Tesla, Palantir and Broadcom jumped, but only one flashed a buy signal. Continue Reading View Comments... Full story

Yahoo Finance • 2 months ago

Stock Market Roars To Key Level As Tesla, Palantir, Broadcom Jump; What To Do Now

The stock market jumped to a key level, but the jury's still out. Tesla, Palantir and Broadcom jumped, but only one flashed a buy signal. Continue Reading View Comments... Full story

Yahoo Finance • 2 months ago

Dow Jones Futures, Bitcoin Rise; Nvidia, Apple, Eli Lilly In Focus

The stock market needs to show a lot of strength after damaging recent losses. Watch Nvidia, Apple and Eli Lilly. Continue Reading View Comments... Full story

Yahoo Finance • 2 months ago

Dow Jones Futures Rise, Bitcoin Bounces; Nvidia, Apple, Eli Lilly In Focus

The stock market needs to show a lot of strength after damaging recent losses. Watch Nvidia, Apple and Eli Lilly. Continue Reading View Comments... Full story

Yahoo Finance • 2 months ago

Dow Jones Futures Due, Weak Link Bitcoin Bounces; Nvidia, Apple, Eli Lilly In Focus

Futures loom as bitcoin, a possible catalyst for stock market woes, rebounded modestly over the weekend. Watch Nvidia, Apple and Eli Lilly. Continue Reading View Comments... Full story

Yahoo Finance • 2 months ago

Dow Jones Futures Due, Nvidia, Apple, Eli Lilly In Focus; Bitcoin Bounces

Stocks rebounded Friday on Fed rate cut hopes but suffered damaging weekly losses. Nvidia, Apple and Eli Lilly are in focus. Bitcoin rallied somewhat over the weekend. Continue Reading View Comments... Full story

Yahoo Finance • 2 months ago

S&P 500 Retailer Leads Five Resilient Stocks After Nvidia-Led Market Sell-Off

S&P 500 components TJX Cos, Cboe Global Markets and RTX are stocks to watch this coming week. The stock market suffered an ugly downside reversal Thursday, with losses on the key indexes and among leading names, as Nvidia gave up early pos... Full story

Yahoo Finance • 3 months ago

Resmed Stock Up on Q1 Earnings & Revenue Beat, Margins Expand

Resmed Inc.’s RMD adjusted earnings per share (EPS) in the first quarter of fiscal 2026 were $2.55, up 15.9% year over year. The metric beat the Zacks Consensus Estimate by 2.41%. The adjustments include certain non-recurring expenses/ben... Full story

Yahoo Finance • 3 months ago

Why Medpace Popped 13% This Week

Key Points Medpace's revenue growth was strong last quarter. The company is building up a backlog as the clinical trial sector recovers. Shares of Medpace are up 100% since the beginning of this year. 10 stocks we like better than Medpace... Full story